Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac Hypertrophy
Mitochondrial unfolding protein response (UPRmt) effectively resists the pathological cardiac hypertrophy and improves the mitochondrial function. However, the specific activation mechanism and drugs that can effectively activate UPRmt in the cardiac muscle are yet to be elucidated. The aim of this...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2020/9187065 |
id |
doaj-765794ef008d4a18aa187493b34ee869 |
---|---|
record_format |
Article |
spelling |
doaj-765794ef008d4a18aa187493b34ee8692021-01-11T02:22:00ZengHindawi LimitedOxidative Medicine and Cellular Longevity1942-09942020-01-01202010.1155/2020/9187065Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac HypertrophyBing Zhang0Yanzhen Tan1Zhengbin Zhang2Pan Feng3Wenyuan Ding4Qian Wang5Hongliang Liang6Weixun Duan7Xiaowu Wang8Shiqiang Yu9Jincheng Liu10Dinghua Yi11Yang Sun12Wei Yi13Department of Cardiovascular SurgeryDepartment of Cardiovascular SurgeryThe 309 Hospital of PLADepartment of Cardiothoracic SurgeryDepartment of Cardiovascular SurgeryDepartment of NutritionDepartment of Cardiovascular SurgeryDepartment of Cardiovascular SurgeryDepartment of Cardiovascular SurgeryDepartment of Cardiovascular SurgeryDepartment of Cardiovascular SurgeryDepartment of Cardiovascular SurgeryDepartment of GeriatricsDepartment of Cardiovascular SurgeryMitochondrial unfolding protein response (UPRmt) effectively resists the pathological cardiac hypertrophy and improves the mitochondrial function. However, the specific activation mechanism and drugs that can effectively activate UPRmt in the cardiac muscle are yet to be elucidated. The aim of this study was to determine the regulation role of UPRmt on preventing pathological cardiac hypertrophy by tetrahydrocurcumin (THC) and explore its underlying molecular mechanism. Male C57BL/6J wild-type (WT) mice were divided into a control group and subjected to sham treatment for 4 weeks, and a test group which was subjected to transverse aortic constriction (TAC) surgery. Animals in the control and test group were orally administered THC (50 mg/kg) for 4 weeks after TAC procedure; an equivalent amount of saline was orally administered in the control sham-treated group and the TAC group. Subsequently, oxidative stress and UPRmt markers were assessed in these mice, and cardiac hypertrophy, fibrosis, and cardiac function were tested. Small interfering RNA (siRNA) targeting proliferator-activated receptor-gamma coactivator (PGC)-1α and activating transcription factor 5 (ATF5) were used to determine the UPRmt activation mechanism. THC supplement partly upregulated UPRmt effectors and inhibited TAC-induced oxidative stress compared with TAC-operated WT mice, thereby substantially attenuating contractile dysfunction, cardiac hypertrophy, and fibrosis. Furthermore, PGC-1α knockdown blunted the UPRmt activation and the cardioprotective role of THC. The interaction between PGC-1α and ATF5 was tested in neonatal rat cardiac myocytes under normal conditions. The results showed that PGC-1α was an upstream effector of ATF5 and partly activated UPRmt. In vitro, phenylephrine- (PE-) induced cardiomyocyte hypertrophy caused ATF5 upregulating rather than downregulating corresponding to the downregulation of PGC-1α. The PGC-1α/ATF5 axis mediated the UPRmt activation and stress-resistance role of THC in vitro. Collectively, the present study provides the first evidence that PGC-1 and ATF5 can form a signaling axis to partly activate UPRmt that mediates the cardioprotective role of THC in pathological cardiac hypertrophy.http://dx.doi.org/10.1155/2020/9187065 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bing Zhang Yanzhen Tan Zhengbin Zhang Pan Feng Wenyuan Ding Qian Wang Hongliang Liang Weixun Duan Xiaowu Wang Shiqiang Yu Jincheng Liu Dinghua Yi Yang Sun Wei Yi |
spellingShingle |
Bing Zhang Yanzhen Tan Zhengbin Zhang Pan Feng Wenyuan Ding Qian Wang Hongliang Liang Weixun Duan Xiaowu Wang Shiqiang Yu Jincheng Liu Dinghua Yi Yang Sun Wei Yi Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac Hypertrophy Oxidative Medicine and Cellular Longevity |
author_facet |
Bing Zhang Yanzhen Tan Zhengbin Zhang Pan Feng Wenyuan Ding Qian Wang Hongliang Liang Weixun Duan Xiaowu Wang Shiqiang Yu Jincheng Liu Dinghua Yi Yang Sun Wei Yi |
author_sort |
Bing Zhang |
title |
Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac Hypertrophy |
title_short |
Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac Hypertrophy |
title_full |
Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac Hypertrophy |
title_fullStr |
Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac Hypertrophy |
title_full_unstemmed |
Novel PGC-1α/ATF5 Axis Partly Activates UPRmt and Mediates Cardioprotective Role of Tetrahydrocurcumin in Pathological Cardiac Hypertrophy |
title_sort |
novel pgc-1α/atf5 axis partly activates uprmt and mediates cardioprotective role of tetrahydrocurcumin in pathological cardiac hypertrophy |
publisher |
Hindawi Limited |
series |
Oxidative Medicine and Cellular Longevity |
issn |
1942-0994 |
publishDate |
2020-01-01 |
description |
Mitochondrial unfolding protein response (UPRmt) effectively resists the pathological cardiac hypertrophy and improves the mitochondrial function. However, the specific activation mechanism and drugs that can effectively activate UPRmt in the cardiac muscle are yet to be elucidated. The aim of this study was to determine the regulation role of UPRmt on preventing pathological cardiac hypertrophy by tetrahydrocurcumin (THC) and explore its underlying molecular mechanism. Male C57BL/6J wild-type (WT) mice were divided into a control group and subjected to sham treatment for 4 weeks, and a test group which was subjected to transverse aortic constriction (TAC) surgery. Animals in the control and test group were orally administered THC (50 mg/kg) for 4 weeks after TAC procedure; an equivalent amount of saline was orally administered in the control sham-treated group and the TAC group. Subsequently, oxidative stress and UPRmt markers were assessed in these mice, and cardiac hypertrophy, fibrosis, and cardiac function were tested. Small interfering RNA (siRNA) targeting proliferator-activated receptor-gamma coactivator (PGC)-1α and activating transcription factor 5 (ATF5) were used to determine the UPRmt activation mechanism. THC supplement partly upregulated UPRmt effectors and inhibited TAC-induced oxidative stress compared with TAC-operated WT mice, thereby substantially attenuating contractile dysfunction, cardiac hypertrophy, and fibrosis. Furthermore, PGC-1α knockdown blunted the UPRmt activation and the cardioprotective role of THC. The interaction between PGC-1α and ATF5 was tested in neonatal rat cardiac myocytes under normal conditions. The results showed that PGC-1α was an upstream effector of ATF5 and partly activated UPRmt. In vitro, phenylephrine- (PE-) induced cardiomyocyte hypertrophy caused ATF5 upregulating rather than downregulating corresponding to the downregulation of PGC-1α. The PGC-1α/ATF5 axis mediated the UPRmt activation and stress-resistance role of THC in vitro. Collectively, the present study provides the first evidence that PGC-1 and ATF5 can form a signaling axis to partly activate UPRmt that mediates the cardioprotective role of THC in pathological cardiac hypertrophy. |
url |
http://dx.doi.org/10.1155/2020/9187065 |
work_keys_str_mv |
AT bingzhang novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT yanzhentan novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT zhengbinzhang novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT panfeng novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT wenyuanding novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT qianwang novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT hongliangliang novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT weixunduan novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT xiaowuwang novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT shiqiangyu novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT jinchengliu novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT dinghuayi novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT yangsun novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy AT weiyi novelpgc1aatf5axispartlyactivatesuprmtandmediatescardioprotectiveroleoftetrahydrocurcumininpathologicalcardiachypertrophy |
_version_ |
1714949896985903104 |